Stay updated on ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Sign up to get notified when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T09:34:53.000Z thumbnail image
  3. Check
    22 days ago
    Change Detected
    Summary
    The page has been updated to include new information about the clinical trial for ARV-471 in breast cancer, including a new revision number and the removal of extensive details about the trial's design and inclusion/exclusion criteria.
    Difference
    19%
    Check dated 2025-04-17T00:43:13.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and a date has been added for February 11, 2025. However, the deletion of the date March 25, 2025, does not significantly impact the core content.
    Difference
    0.3%
    Check dated 2025-04-09T17:22:03.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a new version release, moving from v2.14.2 to v2.14.3, and the last update date has changed from February 11, 2025, to March 25, 2025.
    Difference
    0.2%
    Check dated 2025-04-02T02:46:07.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    1%
    Check dated 2025-02-25T06:04:57.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    The webpage has updated the clinical trial information for ARV-471, including new dates and the removal of previous trial details, indicating a shift in the timeline and status of the trial.
    Difference
    1%
    Check dated 2025-02-18T01:31:23.000Z thumbnail image

Stay in the know with updates to ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ARV-471 & Palbociclib in ER+/HER2- mBC Clinical Trial page.